US equities
|
MU
$972.27
▲+4.68%
META
$613.25
▼-1.12%
TSLA
$400.97
▼-1.59%
SPCX
$144.74
▼-2.58%
NVDA
$217.09
▼-0.39%
SNDK
$1,379.62
▲+5.73%
SKHY
$164.13
▲+12.91%
STX
$685.45
▲+2.63%
MU
$972.27
▲+4.68%
META
$613.25
▼-1.12%
TSLA
$400.97
▼-1.59%
SPCX
$144.74
▼-2.58%
NVDA
$217.09
▼-0.39%
SNDK
$1,379.62
▲+5.73%
SKHY
$164.13
▲+12.91%
STX
$685.45
▲+2.63%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NextSeqâ„¢ 2000
Recent news which mentions NextSeqâ„¢ 2000
Rarebase Is on the Hunt for Therapeutic Opportunities
November 07, 2022
Tickers
ILMN
Tags
Health & Healthcare
Rarebase
NASDAQ: ILMN
From
3BL Media: Corporate Social Responsibility, Energy and Health News